Im so happy, satisfied and delighted with the result
Evidence from clinical trials in diabetic CKD suggests that GLP-1 RAs improve both cardiovascular and renal outcomes by reducing albuminuria and slowing the decline in kidney function
Use of the weighted treatment effect for oral semaglutide reduced the change in HbA1c from 1.30 to 1.11%, increasing CVD and other direct medical costs while decreasing diabetes therapy costs for the oral semaglutide pathway, producing a total cost difference of $US16,585 over 5 years (0.1% increase from base case)
Fuentes cientficas Sikiric P, Seiwerth S, Rucman R, et al
pRTECs that undergo ferroptosis may initiate a chain reaction that reduces the antioxidant capacity of surrounding cells, which in turn leads to oxidative damage to the renal tubules, furtherly promoting crystal aggregation and adhesion
Therefore, we developed a TR-FRET assay to monitor the interaction between his-tagged NSD2 and a biotinylated NSD2 ligand, UNC7096, that is missing the modality for FBXO22-recruitment (Supplementary Fig